CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: scientists test Next-Gen cell therapy
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy for adults with B-cell lymphoma that has come back or hasn't responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look for early signs that the t…
Matched conditions: CLL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug showdown for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study aims to find out which of two daily pill treatments works better for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to a previous standard treatment. About 306 participants will be randomly as…
Matched conditions: CLL
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC